Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0002274,GO:0002274,myeloid leukocyte activation,18/134,232/18800,5.8720848862985e-14,1.84853232220677e-10,1.21644874276163e-10,C1QA/CD74/CHGA/CSF1/HAVCR1/HAVCR2/IL15/IL1RL1/IL4R/IL6/ITGAM/LGALS9/LTBR/NECTIN2/PTGDS/TGFBR2/TREM2/VSIG4,18
GO:0019221,GO:0019221,cytokine-mediated signaling pathway,22/134,486/18800,4.5713844813511796e-12,7.195359173646761e-09,4.73499192594691e-09,CCL20/CCL7/CD74/CSF1/CXCL9/EDA2R/EPO/IL10RB/IL15/IL1R1/IL1RL1/IL2RA/IL4R/IL6/MMP12/TFF2/TNFRSF11A/TNFRSF1A/TNFRSF1B/TNFRSF4/TREM2/YAP1,22
GO:0002696,GO:0002696,positive regulation of leukocyte activation,19/134,421/18800,1.58421436733293e-10,1.66236894278802e-07,1.09394171049516e-07,CD27/CD74/CD83/EPO/HAVCR1/HAVCR2/IGFBP2/IL15/IL1RL1/IL2RA/IL4R/IL6/ITGAM/LGALS9/NECTIN2/SIRPB1/TGFBR2/TNFRSF4/TREM2,19
GO:0046718,GO:0046718,viral entry into host cell,12/134,146/18800,5.71000584911619e-10,3.59501968260355e-07,2.36574558127593e-07,CD74/CLEC5A/EGFR/EPHA2/HAVCR1/ITGAV/LGALS9/NECTIN2/NECTIN4/SCARB2/SIGLEC1/TNFRSF4,12
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,14/134,233/18800,1.25170538166865e-09,5.62909791641845e-07,3.70429502424648e-07,CD74/CSF1/EPO/HAVCR2/IGFBP2/IL15/IL2RA/IL6/LGALS9/MZB1/TGFBR2/TNFRSF1B/TNFRSF4/VSIG4,14
GO:0043410,GO:0043410,positive regulation of MAPK cascade,19/134,491/18800,2.0646104875531703e-09,8.12424226852174e-07,5.34625452566401e-07,CCL20/CCL7/CD27/CD74/EDA2R/EFNA1/EGFR/EPO/FGF23/GDF15/HAVCR2/HGF/IGFBP4/IL6/LGALS9/LTBR/TGFA/TNFRSF11A/TREM2,19
GO:0022409,GO:0022409,positive regulation of cell-cell adhesion,15/134,291/18800,2.5668730128183402e-09,8.9783513826135e-07,5.90831121546959e-07,CD27/CD74/CD83/EPO/FSTL3/HAVCR2/IGFBP2/IL15/IL2RA/IL4R/IL6/LGALS9/PLAUR/SIRPB1/TGFBR2,15
GO:0050730,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,14/134,261/18800,5.41144678500479e-09,1.41960287326626e-06,9.34186602885038e-07,AREG/CD74/CLEC6A/EFNA1/EGFR/EPO/GFRA1/HGF/IL15/IL6/SPINK1/TGFA/TNFRSF1A/TREM2,14
GO:0050870,GO:0050870,positive regulation of T cell activation,13/134,223/18800,7.242250832998661e-09,1.62847183016284e-06,1.07163531122867e-06,CD27/CD74/CD83/EPO/HAVCR2/IGFBP2/IL15/IL2RA/IL4R/IL6/LGALS9/SIRPB1/TGFBR2,13
GO:0050670,GO:0050670,regulation of lymphocyte proliferation,13/134,230/18800,1.04924064284893e-08,2.01753821413207e-06,1.32766508573929e-06,CD74/EPO/HAVCR2/IGFBP2/IL15/IL2RA/IL6/LGALS9/MZB1/TGFBR2/TNFRSF1B/TNFRSF4/VSIG4,13
GO:0070661,GO:0070661,leukocyte proliferation,15/134,330/18800,1.40033859621908e-08,2.20413295044883e-06,1.45045597755745e-06,CD74/CSF1/EPO/HAVCR2/IGFBP2/IL15/IL2RA/IL6/LGALS9/MZB1/TGFBR2/TNFRSF1B/TNFRSF4/TREM2/VSIG4,15
GO:0050863,GO:0050863,regulation of T cell activation,15/134,342/18800,2.25231342559168e-08,2.95428444323442e-06,1.94410211472124e-06,CD27/CD74/CD83/EPO/HAVCR2/IGFBP2/IL15/IL2RA/IL4R/IL6/LGALS9/SIRPB1/TGFBR2/TNFRSF1B/VSIG4,15
GO:0002443,GO:0002443,leukocyte mediated immunity,17/134,457/18800,2.78498976081187e-08,3.5068591068143e-06,2.30773046285379e-06,C1QA/C9/CD27/CD74/CHGA/HAVCR2/IL1R1/IL4R/IL6/ITGAM/LGALS9/NECTIN2/PTGDS/SPON2/TNFRSF1B/TREM2/ULBP2,17
GO:0097529,GO:0097529,myeloid leukocyte migration,12/134,229/18800,9.11362961354047e-08,9.89300207704324e-06,6.51020801431857e-06,CCL20/CCL7/CD74/CHGA/CSF1/CXCL9/IL1R1/IL6/NBL1/PGF/TNFRSF11A/TREM2,12
GO:1902107,GO:1902107,positive regulation of leukocyte differentiation,10/134,157/18800,1.85871505745218e-07,1.77310151541196e-05,1.16681060065898e-05,CD27/CD74/CD83/CSF1/IL15/IL2RA/IL4R/LGALS9/TGFBR2/TREM2,10
GO:1903708,GO:1903708,positive regulation of hemopoiesis,10/134,157/18800,1.85871505745218e-07,1.77310151541196e-05,1.16681060065898e-05,CD27/CD74/CD83/CSF1/IL15/IL2RA/IL4R/LGALS9/TGFBR2/TREM2,10
GO:0046651,GO:0046651,lymphocyte proliferation,13/134,296/18800,2.02556147955052e-07,1.87543162871325e-05,1.23415015224626e-05,CD74/EPO/HAVCR2/IGFBP2/IL15/IL2RA/IL6/LGALS9/MZB1/TGFBR2/TNFRSF1B/TNFRSF4/VSIG4,13
GO:0002697,GO:0002697,regulation of immune effector process,14/134,353/18800,2.34194197617454e-07,2.09580618065559e-05,1.37917025464127e-05,CD74/HAVCR2/IL1R1/IL4R/IL6/ITGAM/LGALS9/MZB1/NECTIN2/SPON2/TNFRSF1B/TNFRSF4/TREM2/VSIG4,14
GO:0010951,GO:0010951,negative regulation of endopeptidase activity,12/134,251/18800,2.46330459606914e-07,2.09580618065559e-05,1.37917025464127e-05,AMBP/CD27/COL6A3/CST3/CSTB/FABP1/HGF/PLAUR/SPINK1/SPINK4/SPINT1/WFDC2,12
GO:0001819,GO:0001819,positive regulation of cytokine production,16/134,475/18800,2.82569030838836e-07,2.28669479909139e-05,1.5047867868026e-05,CD74/CD83/CLEC5A/CLEC6A/HAVCR2/HGF/IL15/IL1R1/IL1RL1/IL4R/IL6/LGALS9/MMP12/SPON2/TNFRSF8/TREM2,16
GO:0060326,GO:0060326,cell chemotaxis,13/134,315/18800,4.12266200997807e-07,3.09866279558916e-05,2.03911201154266e-05,CCL20/CCL7/CD74/CHGA/CSF1/CXCL9/EPHA2/HGF/IL6/LGALS9/NBL1/PGF/TNFRSF11A,13
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,14/134,370/18800,4.13417526730448e-07,3.09866279558916e-05,2.03911201154266e-05,C1QA/C9/CD27/CD74/CLEC6A/HAVCR2/IL18BP/IL1R1/IL1RL1/IL4R/IL6/NECTIN2/TNFRSF1B/TREM2,14
GO:0006959,GO:0006959,humoral immune response,13/134,317/18800,4.42970387634038e-07,3.16925177334534e-05,2.08556393029614e-05,C1QA/C9/CD83/CXCL9/IL6/REG1A/REG1B/REG3A/RNASE6/SPON2/TREM2/VSIG4/WFDC2,13
GO:0032602,GO:0032602,chemokine production,8/134,98/18800,4.95795426606723e-07,3.32077447437865e-05,2.18527525097879e-05,CD74/EPHA2/HAVCR2/IL1RL1/IL4R/IL6/LGALS9/TREM2,8
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,14/134,381/18800,5.87370863000795e-07,3.85217390984688e-05,2.53496898768764e-05,CD27/CD74/CD83/EPO/HAVCR2/IGFBP2/IL15/IL2RA/IL4R/IL6/LGALS9/SIRPB1/TGFBR2/VSIG4,14
GO:0032103,GO:0032103,positive regulation of response to external stimulus,15/134,442/18800,6.21686571525504e-07,3.99401903502508e-05,2.62831186415079e-05,CCL7/CD74/CLEC6A/CSF1/HAVCR2/IL15/IL1RL1/IL6/LGALS9/MMP12/NECTIN2/PGF/TNFRSF11A/TNFRSF1A/TREM2,15
GO:0002687,GO:0002687,positive regulation of leukocyte migration,9/134,141/18800,7.66064338285796e-07,4.63763564793017e-05,3.05185145292803e-05,CCL20/CCL7/CD74/CSF1/IL1R1/IL6/LGALS9/PGF/TREM2,9
GO:0044278,GO:0044278,cell wall disruption in another organism,3/134,4/18800,1.40899727511849e-06,7.64745417598794e-05,5.03249843454299e-05,REG1A/REG1B/REG3A,3
GO:0150062,GO:0150062,complement-mediated synapse pruning,3/134,4/18800,1.40899727511849e-06,7.64745417598794e-05,5.03249843454299e-05,C1QA/ITGAM/TREM2,3
GO:0052548,GO:0052548,regulation of endopeptidase activity,14/134,426/18800,2.19381470354265e-06,0.0001132152243729,7.45026287587908e-05,AMBP/CD27/COL6A3/CST3/CSTB/EFNA1/FABP1/HGF/LGALS9/PLAUR/SPINK1/SPINK4/SPINT1/WFDC2,14
GO:0051346,GO:0051346,negative regulation of hydrolase activity,13/134,371/18800,2.56494553880672e-06,0.0001302330412284,8.57014061183636e-05,AMBP/ANGPTL4/CD27/COL6A3/CST3/CSTB/FABP1/HGF/PLAUR/SPINK1/SPINK4/SPINT1/WFDC2,13
GO:1903131,GO:1903131,mononuclear cell differentiation,14/134,433/18800,2.65162571203069e-06,0.0001313648175966,8.64461850566097e-05,CD27/CD74/CD79B/CD83/CSF1/DLL1/IL15/IL2RA/IL4R/IL6/LGALS9/LTBR/TGFBR2/TREM2,14
GO:0002573,GO:0002573,myeloid leukocyte differentiation,10/134,210/18800,2.67069514809038e-06,0.0001313648175966,8.64461850566097e-05,CD74/CSF1/EPHA2/FSTL3/IL15/LTBR/OSCAR/TGFBR2/TNFRSF11A/TREM2,10
GO:0050679,GO:0050679,positive regulation of epithelial cell proliferation,10/134,211/18800,2.78676981171429e-06,0.0001333435606295,8.77483205105946e-05,ACVRL1/AREG/B4GALT1/EGFR/MMP12/PGF/REG3A/SPINK1/TGFA/YAP1,10
GO:0022612,GO:0022612,gland morphogenesis,8/134,123/18800,2.79564008943815e-06,0.0001333435606295,8.77483205105946e-05,AREG/CSF1/EGFR/EPHA2/HGF/IL6/TGFA/TGFBR2,8
GO:0044706,GO:0044706,multi-multicellular organism process,10/134,213/18800,3.03214539082351e-06,0.0001403704954457,9.23724787792673e-05,ADM/AMBP/B4GALT1/EPO/HAVCR2/IGFBP2/IGFBP7/LGALS9/PGF/TGFBR2,10
GO:0050673,GO:0050673,epithelial cell proliferation,14/134,443/18800,3.4535785909812e-06,0.0001575632667305,0.0001036863869878,ACVRL1/AREG/B4GALT1/EGFR/EPHA2/HGF/IGFBP4/IL6/MMP12/PGF/REG3A/SPINK1/TGFA/YAP1,14
GO:0002822,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,9/134,173/18800,4.1856592251413e-06,0.0001816080421934,0.0001195093382721,CLEC6A/HAVCR2/IL1R1/IL1RL1/IL4R/IL6/NECTIN2/TNFRSF1B/TREM2,9
GO:0097191,GO:0097191,extrinsic apoptotic signaling pathway,10/134,221/18800,4.21136819571771e-06,0.0001816080421934,0.0001195093382721,CD27/HGF/ITGAV/LTBR/TNFRSF10A/TNFRSF10B/TNFRSF12A/TNFRSF1A/TNFRSF1B/YAP1,10
GO:0002275,GO:0002275,myeloid cell activation involved in immune response,7/134,93/18800,4.543721111791e-06,0.0001909430453724,0.0001256523484561,CHGA/HAVCR2/IL4R/ITGAM/LGALS9/PTGDS/TREM2,7
GO:0070371,GO:0070371,ERK1 and ERK2 cascade,12/134,335/18800,5.07629611521824e-06,0.0002048741047526,0.0001348198482422,CCL20/CCL7/CD74/EGFR/EPHA2/EPO/FGF23/HAVCR2/ITGAV/LGALS9/TNFRSF11A/TREM2,12
GO:0045765,GO:0045765,regulation of angiogenesis,12/134,345/18800,6.84228144209061e-06,0.0002581939914075,0.0001699076356216,ACVRL1/ADAM12/ADM/ANGPTL4/DLL1/EFNA1/EPHA2/HGF/IL6/PGF/TGFBR2/THBS2,12
GO:0051384,GO:0051384,response to glucocorticoid,8/134,139/18800,6.94740862209517e-06,0.0002581939914075,0.0001699076356216,ADM/AREG/EPO/IGFBP2/IGFBP7/IL22/IL6/NEFL,8
GO:0007565,GO:0007565,female pregnancy,9/134,185/18800,7.22358324818679e-06,0.0002613774720148,0.0001720025630058,ADM/AMBP/EPO/HAVCR2/IGFBP2/IGFBP7/LGALS9/PGF/TGFBR2,9
GO:0061138,GO:0061138,morphogenesis of a branching epithelium,9/134,185/18800,7.22358324818679e-06,0.0002613774720148,0.0001720025630058,ADM/AREG/COL4A1/CSF1/EPHA2/HGF/SPINT1/TGFBR2/YAP1,9
GO:0033674,GO:0033674,positive regulation of kinase activity,14/134,476/18800,7.85321204473857e-06,0.0002809308126913,0.0001848698720579,AREG/CD74/CSF1/EFNA1/EGFR/EPHA2/EPHB4/EPO/TGFA/TGFBR2/TNFRSF10A/TNFRSF10B/TNFRSF11A/TREM2,14
GO:0001503,GO:0001503,ossification,13/134,420/18800,9.81854507751342e-06,0.0003359649989566,0.000221085774743,AREG/CLEC5A/CSF1/EGFR/EPHA2/FGF23/FSTL3/HGF/IL6/ITGA11/SMOC1/TNFRSF11A/YAP1,13
GO:0001763,GO:0001763,morphogenesis of a branching structure,9/134,199/18800,1.29905717789792e-05,0.0004259824995856,0.0002803228647042,ADM/AREG/COL4A1/CSF1/EPHA2/HGF/SPINT1/TGFBR2/YAP1,9
GO:0007568,GO:0007568,aging,8/134,163/18800,2.22087689125819e-05,0.0006854235738902,0.0004510511581007,ADM/C1QA/EPO/GFRA1/IGFBP2/IL15/TGFBR2/TNFRSF1B,8
GO:0031348,GO:0031348,negative regulation of defense response,10/134,268/18800,2.26559879416723e-05,0.0006917126312867,0.0004551897473324,HAVCR2/HGF/IL2RA/LGALS9/MMP12/SIGLEC10/TNFRSF1A/TNFRSF1B/TREM2/VSIG4,10
GO:0006953,GO:0006953,acute-phase response,5/134,48/18800,2.28520056079489e-05,0.0006917126312867,0.0004551897473324,EPO/IL22/IL6/REG3A/TNFRSF11A,5
GO:0060143,GO:0060143,positive regulation of syncytium formation by plasma membrane fusion,4/134,24/18800,2.34732064510968e-05,0.0007037490848385,0.0004631104791554,CXCL9/GDF15/IL4R/TREM2,4
GO:0002702,GO:0002702,positive regulation of production of molecular mediator of immune response,7/134,120/18800,2.43302198239412e-05,0.0007225616226959,0.0004754902940766,CD74/IL1R1/IL4R/IL6/MZB1/SPON2/TNFRSF4,7
GO:0032496,GO:0032496,response to lipopolysaccharide,11/134,333/18800,2.70285118887073e-05,0.0007819466652902,0.0005145693296633,ADM/CXCL9/EPO/HAVCR2/IL18BP/IL6/LGALS9/SPON2/TNFRSF11A/TNFRSF1B/TREM2,11
GO:0019730,GO:0019730,antimicrobial humoral response,7/134,122/18800,2.70750274830499e-05,0.0007819466652902,0.0005145693296633,CXCL9/REG1A/REG1B/REG3A/RNASE6/SPON2/WFDC2,7
GO:0031349,GO:0031349,positive regulation of defense response,10/134,289/18800,4.3002329162507e-05,0.0011874678263471,0.0007814273664987,CLEC6A/HAVCR2/IL15/IL1RL1/IL6/MMP12/NECTIN2/TNFRSF11A/TNFRSF1A/TREM2,10
GO:0001649,GO:0001649,osteoblast differentiation,9/134,241/18800,5.84918494676063e-05,0.0014181694793906,0.0009332433409485,AREG/CLEC5A/EPHA2/FGF23/HGF/IL6/ITGA11/SMOC1/YAP1,9
GO:0042742,GO:0042742,defense response to bacterium,11/134,364/18800,6.05725682082956e-05,0.0014555911810665,0.0009578691380789,CCL20/CHGA/COLEC12/EPHA2/HAVCR2/IL6/RNASE6/SPON2/TNFRSF1A/TREM2/WFDC2,11
GO:0000768,GO:0000768,syncytium formation by plasma membrane fusion,5/134,59/18800,6.27522394498527e-05,0.0014742093267771,0.0009701210309293,ADAM12/CXCL9/GDF15/IL4R/TREM2,5
GO:0140253,GO:0140253,cell-cell fusion,5/134,59/18800,6.27522394498527e-05,0.0014742093267771,0.0009701210309293,ADAM12/CXCL9/GDF15/IL4R/TREM2,5
GO:0050921,GO:0050921,positive regulation of chemotaxis,7/134,140/18800,6.52892622387416e-05,0.0015112543935849,0.0009944989789925,CCL7/CD74/CSF1/IL6/LGALS9/PGF/TREM2,7
GO:0002507,GO:0002507,tolerance induction,4/134,31/18800,6.68708846850308e-05,0.0015365660218137,0.0010111555978497,HAVCR2/IL2RA/LGALS9/TGFBR2,4
GO:0070555,GO:0070555,response to interleukin-1,7/134,141/18800,6.82966512237885e-05,0.0015467471802337,0.0010178554305824,CCL20/CCL7/EPO/IL1R1/IL6/LGALS9/TNFRSF11A,7
GO:0030198,GO:0030198,extracellular matrix organization,10/134,307/18800,7.1292195030139e-05,0.0016030559282491,0.0010549100738294,B4GALT1/COL18A1/COL4A1/CST3/IL6/MMP12/SMOC1/SPINT1/TNFRSF1A/TNFRSF1B,10
GO:0060760,GO:0060760,positive regulation of response to cytokine stimulus,5/134,64/18800,9.28856956197936e-05,0.0020075458059155,0.0013210894623292,CD74/CSF1/IL1R1/MMP12/TREM2,5
GO:0031100,GO:0031100,animal organ regeneration,5/134,65/18800,0.0001000548880575,0.0021281945108456,0.0014004837816305,ADM/HGF/IL6/PGF/TGFBR2,5
GO:0043627,GO:0043627,response to estrogen,5/134,68/18800,0.0001241332066741,0.0025540610105239,0.0016807303112122,EPO/IGFBP2/IL4R/KRT19/TGFBR2,5
GO:0071887,GO:0071887,leukocyte apoptotic process,6/134,109/18800,0.0001301228247422,0.00264275259541,0.001739094866504,CD27/CD74/EFNA1/IL2RA/IL6/LGALS9,6
GO:0071260,GO:0071260,cellular response to mechanical stimulus,5/134,70/18800,0.0001424949572836,0.0028571600352153,0.0018801882395852,LTBR/TNFRSF10A/TNFRSF10B/TNFRSF1A/TNFRSF8,5
GO:0014028,GO:0014028,notochord formation,2/134,3/18800,0.0001505730470897,0.0029625247014902,0.0019495247149511,EFNA1/EPHA2,2
GO:0150064,GO:0150064,vertebrate eye-specific patterning,2/134,3/18800,0.0001505730470897,0.0029625247014902,0.0019495247149511,C1QA/ITGAM,2
GO:0150076,GO:0150076,neuroinflammatory response,5/134,73/18800,0.0001738499769677,0.0033575443404569,0.0022094720999195,C1QA/IL6/ITGAM/TNFRSF1B/TREM2,5
GO:0051048,GO:0051048,negative regulation of secretion,7/134,167/18800,0.000196259964625,0.0037218455942151,0.0024492048851118,CD74/CHGA/FGF23/LGALS9/TFF2/TNFRSF1A/TNFRSF1B,7
GO:0043299,GO:0043299,leukocyte degranulation,5/134,76/18800,0.0002102170044417,0.0039390662498962,0.0025921495284544,CHGA/IL4R/ITGAM/LGALS9/PTGDS,5
GO:0002830,GO:0002830,positive regulation of type 2 immune response,3/134,17/18800,0.0002237875019543,0.0041197839541075,0.002711072969198,CD74/IL4R/IL6,3
GO:0038065,GO:0038065,collagen-activated signaling pathway,3/134,17/18800,0.0002237875019543,0.0041197839541075,0.002711072969198,COL4A1/ITGA11/OSCAR,3
GO:0014002,GO:0014002,astrocyte development,4/134,43/18800,0.0002454852403878,0.0043908382769369,0.0028894434993018,C1QA/DLL1/IL6/TREM2,4
GO:0032102,GO:0032102,negative regulation of response to external stimulus,11/134,429/18800,0.0002555934020618,0.0044950169256459,0.0029579995016622,HAVCR2/HGF/IL2RA/LGALS9/MMP12/NBL1/SIGLEC10/TNFRSF1A/TNFRSF1B/TREM2/VSIG4,11
GO:0042060,GO:0042060,wound healing,11/134,429/18800,0.0002555934020618,0.0044950169256459,0.0029579995016622,ACVRL1/B4GALT1/IL6/MMP12/OCLN/PLAUR/REG3A/TGFA/TGFBR2/TNFRSF12A/YAP1,11
GO:0001570,GO:0001570,vasculogenesis,5/134,80/18800,0.0002673926417318,0.0045945562213,0.0030235025224097,ADM/EPHA2/ITGAV/TGFBR2/YAP1,5
GO:0050868,GO:0050868,negative regulation of T cell activation,6/134,125/18800,0.0002746968444936,0.0046743008998165,0.0030759794592519,CD74/HAVCR2/IL2RA/IL4R/LGALS9/VSIG4,6
GO:0001906,GO:0001906,cell killing,7/134,185/18800,0.0003660637181461,0.0058495867244879,0.0038493903142487,C9/CHGA/HAVCR2/ITGAM/LGALS9/NECTIN2/ULBP2,7
GO:0033627,GO:0033627,cell adhesion mediated by integrin,5/134,86/18800,0.0003743894377322,0.0058823703446093,0.003870963966492,EFNA1/EPHA2/ITGA11/ITGAM/ITGAV,5
GO:0071496,GO:0071496,cellular response to external stimulus,9/134,309/18800,0.0003774583257976,0.0058823703446093,0.003870963966492,ASGR1/DSC2/FGF23/IL15/LTBR/TNFRSF10A/TNFRSF10B/TNFRSF1A/TNFRSF8,9
GO:0006909,GO:0006909,phagocytosis,9/134,310/18800,0.0003864336463053,0.0059814399817508,0.0039361579228535,CD302/COLEC12/HAVCR1/IL15/ITGAM/ITGAV/SIRPB1/SPON2/TREM2,9
GO:0006898,GO:0006898,receptor-mediated endocytosis,8/134,246/18800,0.0003876155515492,0.0059814399817508,0.0039361579228535,ADM/ASGR1/DLL1/ITGAM/ITGAV/SCARB2/SIGLEC1/TGFBR2,8
GO:0031099,GO:0031099,regeneration,7/134,188/18800,0.0004032913508644,0.0061929813293726,0.0040753652297884,ADM/HGF/IL6/NEFL/PGF/TGFBR2/YAP1,7
GO:0034612,GO:0034612,response to tumor necrosis factor,8/134,249/18800,0.0004201520864905,0.0063074149716793,0.004150669653001,CCL20/CCL7/EDA2R/IL18BP/TNFRSF11A/TNFRSF1A/TNFRSF1B/TNFRSF4,8
GO:0002269,GO:0002269,leukocyte activation involved in inflammatory response,4/134,50/18800,0.0004407977426205,0.0063074149716793,0.004150669653001,C1QA/IL6/ITGAM/TREM2,4
GO:0030857,GO:0030857,negative regulation of epithelial cell differentiation,4/134,50/18800,0.0004407977426205,0.0063074149716793,0.004150669653001,ACVRL1/DLL1/REG3A/YAP1,4
GO:0043303,GO:0043303,mast cell degranulation,4/134,50/18800,0.0004407977426205,0.0063074149716793,0.004150669653001,CHGA/IL4R/LGALS9/PTGDS,4
GO:0052372,GO:0052372,modulation by symbiont of entry into host,4/134,50/18800,0.0004407977426205,0.0063074149716793,0.004150669653001,CD74/ITGAV/LGALS9/NECTIN2,4
GO:0010888,GO:0010888,negative regulation of lipid storage,3/134,22/18800,0.0004937699521848,0.0068652049307362,0.004517729988527,IL6/ITGAV/TREM2,3
GO:0060309,GO:0060309,elastin catabolic process,2/134,5/18800,0.0004972257700787,0.0068652049307362,0.004517729988527,CST3/MMP12,2
GO:0110088,GO:0110088,hippocampal neuron apoptotic process,2/134,5/18800,0.0004972257700787,0.0068652049307362,0.004517729988527,ITGAM/TREM2,2
GO:0110089,GO:0110089,regulation of hippocampal neuron apoptotic process,2/134,5/18800,0.0004972257700787,0.0068652049307362,0.004517729988527,ITGAM/TREM2,2
GO:1902339,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,2/134,5/18800,0.0004972257700787,0.0068652049307362,0.004517729988527,TNFRSF1A/TNFRSF1B,2
GO:0048013,GO:0048013,ephrin receptor signaling pathway,4/134,52/18800,0.0005125052146806,0.0070146365904984,0.0046160652745606,EFNA1/EFNA4/EPHA2/EPHB4,4
GO:0009612,GO:0009612,response to mechanical stimulus,7/134,201/18800,0.0006011486196729,0.0079513271207158,0.005232465650227,IGFBP2/LTBR/TGFBR2/TNFRSF10A/TNFRSF10B/TNFRSF1A/TNFRSF8,7
GO:0009991,GO:0009991,response to extracellular stimulus,11/134,479/18800,0.0006451139384706,0.0084266335199397,0.0055452466953927,ADM/ASGR1/DSC2/EPO/FGF23/GAST/GDF15/IGFBP2/IL15/SPINK1/TGFBR2,11
GO:1990868,GO:1990868,response to chemokine,5/134,97/18800,0.0006508996717024,0.008432231137939,0.005548930274682,CCL20/CCL7/CXCL9/TFF2/TREM2,5
GO:0070228,GO:0070228,regulation of lymphocyte apoptotic process,4/134,57/18800,0.0007275249257351,0.0092722609968187,0.0061017219426667,CD27/CD74/EFNA1/LGALS9,4
GO:2001188,GO:2001188,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,2/134,6/18800,0.0007423528721972,0.0093104655046891,0.0061268628747502,HAVCR2/LGALS9,2
GO:0002367,GO:0002367,cytokine production involved in immune response,5/134,100/18800,0.0007475802076325,0.0093388194191554,0.0061455215063525,CD74/IL1R1/IL6/SPON2/TNFRSF1B,5
GO:1901652,GO:1901652,response to peptide,11/134,491/18800,0.000790280884118,0.0097945048157625,0.0064453907167193,ADM/AREG/GDF15/MMP12/MZB1/NEFL/REG1A/REG1B/REG3A/SPINK1/TREM2,11
GO:0035710,GO:0035710,"CD4-positive, alpha-beta T cell activation",5/134,102/18800,0.0008177415279688,0.0100165382492059,0.0065915024658721,CD83/IL4R/IL6/LGALS9/TGFBR2,5
GO:0016064,GO:0016064,immunoglobulin mediated immune response,7/134,216/18800,0.0009179836337721,0.0110298186225755,0.0072583037013404,C1QA/C9/CD27/CD74/IL4R/NECTIN2/TREM2,7
GO:0050866,GO:0050866,negative regulation of cell activation,7/134,216/18800,0.0009179836337721,0.0110298186225755,0.0072583037013404,CD74/HAVCR2/IL2RA/IL4R/LGALS9/TREM2/VSIG4,7
GO:0010668,GO:0010668,ectodermal cell differentiation,2/134,7/18800,0.0010344394091602,0.0119669441099162,0.0078749903057296,EDA2R/ITGAM,2
GO:0046836,GO:0046836,glycolipid transport,2/134,7/18800,0.0010344394091602,0.0119669441099162,0.0078749903057296,NPC2/PSAP,2
GO:0001666,GO:0001666,response to hypoxia,8/134,286/18800,0.0010377940730645,0.0119669441099162,0.0078749903057296,ACVRL1/ADM/ANGPTL4/EPO/FABP1/PGF/TGFBR2/TREM2,8
GO:0003170,GO:0003170,heart valve development,4/134,65/18800,0.0011934154986875,0.0133963804675365,0.0088156479502814,EFNA1/TGFBR2/TNFRSF1A/TNFRSF1B,4
GO:0045088,GO:0045088,regulation of innate immune response,7/134,231/18800,0.0013539832138963,0.0146990809384283,0.0096729055329455,CLEC6A/HAVCR2/LGALS9/MMP12/NECTIN2/TREM2/VSIG4,7
GO:0002858,GO:0002858,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,2/134,8/18800,0.0013728135206545,0.0146990809384283,0.0096729055329455,HAVCR2/NECTIN2,2
GO:0045136,GO:0045136,development of secondary sexual characteristics,2/134,8/18800,0.0013728135206545,0.0146990809384283,0.0096729055329455,AREG/B4GALT1,2
GO:0007160,GO:0007160,cell-matrix adhesion,7/134,235/18800,0.0014939290613088,0.0155724790894048,0.0102476556035407,ACVRL1/CSF1/ITGA11/ITGAM/ITGAV/MMP12/SIGLEC1,7
GO:0033028,GO:0033028,myeloid cell apoptotic process,3/134,32/18800,0.0015097114569007,0.0155822021846676,0.0102540540023493,CLEC5A/EPO/IL6,3
GO:0048771,GO:0048771,tissue remodeling,6/134,174/18800,0.0015585614242053,0.0160114288011219,0.0105365116968528,ACVRL1/CST3/EPHA2/IL15/IL6/TNFRSF11A,6
GO:0150063,GO:0150063,visual system development,9/134,383/18800,0.0017164916440305,0.0173746485382894,0.0114335947045254,ACVRL1/C1QA/COL4A1/DLL1/EGFR/EPHA2/ITGAM/SMOC1/TGFBR2,9
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,4/134,72/18800,0.0017452223350541,0.0173913181883184,0.011444564366552,HAVCR2/LGALS9/NECTIN2/ULBP2,4
GO:0002420,GO:0002420,natural killer cell mediated cytotoxicity directed against tumor cell target,2/134,9/18800,0.0017568104141948,0.0173913181883184,0.011444564366552,HAVCR2/NECTIN2,2
GO:0002579,GO:0002579,positive regulation of antigen processing and presentation,2/134,9/18800,0.0017568104141948,0.0173913181883184,0.011444564366552,CD74/TREM2,2
GO:0034351,GO:0034351,negative regulation of glial cell apoptotic process,2/134,9/18800,0.0017568104141948,0.0173913181883184,0.011444564366552,DLL1/TREM2,2
GO:0051541,GO:0051541,elastin metabolic process,2/134,9/18800,0.0017568104141948,0.0173913181883184,0.011444564366552,CST3/MMP12,2
GO:0002440,GO:0002440,production of molecular mediator of immune response,8/134,312/18800,0.0018002675258329,0.0176776275656814,0.0116329736672443,CD74/IL1R1/IL4R/IL6/MZB1/SPON2/TNFRSF1B/TNFRSF4,8
GO:0002495,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,3/134,34/18800,0.0018025789226758,0.0176776275656814,0.0116329736672443,CD74/IFI30/TREM2,3
GO:0042058,GO:0042058,regulation of epidermal growth factor receptor signaling pathway,4/134,73/18800,0.0018363163847982,0.0177897601089674,0.0117067638248003,AREG/EGFR/PLAUR/TGFA,4
GO:1901214,GO:1901214,regulation of neuron death,8/134,313/18800,0.0018366175461926,0.0177897601089674,0.0117067638248003,C1QA/CHGA/CSF1/EPO/ITGAM/NEFL/TNFRSF1B/TREM2,8
GO:0009615,GO:0009615,response to virus,9/134,392/18800,0.0020097835304452,0.0190566221501255,0.0125404375013198,CXCL9/IL10RB/IL15/IL6/LGALS9/MMP12/NPC2/RNASE6/SPON2,9
GO:0042542,GO:0042542,response to hydrogen peroxide,5/134,128/18800,0.0022424127535413,0.0201689009947088,0.0132723858615619,AREG/FABP1/HGF/IL18BP/IL6,5
GO:0042092,GO:0042092,type 2 immune response,3/134,37/18800,0.0023044372364724,0.0205506187547178,0.0135235797864257,CD74/IL4R/IL6,3
GO:0071216,GO:0071216,cellular response to biotic stimulus,7/134,256/18800,0.0024237778707112,0.0215538212909575,0.0141837491809685,CXCL9/HAVCR2/IGFBPL1/IL6/SPON2/TNFRSF1B/TREM2,7
GO:0032418,GO:0032418,lysosome localization,4/134,79/18800,0.0024530722663064,0.021570590766292,0.0141947845342281,CHGA/IL4R/LGALS9/PTGDS,4
GO:1990849,GO:1990849,vacuolar localization,4/134,79/18800,0.0024530722663064,0.021570590766292,0.0141947845342281,CHGA/IL4R/LGALS9/PTGDS,4
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,5/134,131/18800,0.0024800939725036,0.0215852490925075,0.0142044306206296,HAVCR2/ITGAM/LGALS9/NECTIN2/ULBP2,5
GO:0009595,GO:0009595,detection of biotic stimulus,3/134,39/18800,0.0026825037744284,0.0228230321132456,0.0150189685009253,CLEC6A/TREM2/YAP1,3
GO:0019216,GO:0019216,regulation of lipid metabolic process,8/134,339/18800,0.0030040682210706,0.025285579572006,0.0166394772278833,ADM/CD74/FABP1/IGFBP7/NPC2/PIK3IP1/PSAP/TREM2,8
GO:1903800,GO:1903800,positive regulation of production of miRNAs involved in gene silencing by miRNA,2/134,12/18800,0.0031759945103707,0.0257572502486214,0.0169498657424219,EGFR/IL6,2
GO:0001910,GO:0001910,regulation of leukocyte mediated cytotoxicity,4/134,85/18800,0.0031992010315155,0.0257572502486214,0.0169498657424219,HAVCR2/ITGAM/LGALS9/NECTIN2,4
GO:0002347,GO:0002347,response to tumor cell,3/134,42/18800,0.0033176900464942,0.026440729788263,0.0173996376055981,HAVCR2/IGFBPL1/NECTIN2,3
GO:0071354,GO:0071354,cellular response to interleukin-6,3/134,42/18800,0.0033176900464942,0.026440729788263,0.0173996376055981,FGF23/IL6/YAP1,3
GO:0034103,GO:0034103,regulation of tissue remodeling,4/134,86/18800,0.0033369967190171,0.0265274385643083,0.0174566973498825,CST3/IL15/IL6/TNFRSF11A,4
GO:0002064,GO:0002064,epithelial cell development,6/134,203/18800,0.0033678385237984,0.0266380795801948,0.0175295059900433,B4GALT1/COL18A1/DLL1/EPHA2/TNFRSF1A/YAP1,6
GO:0001894,GO:0001894,tissue homeostasis,7/134,272/18800,0.0033914960138908,0.0267579685506981,0.0176084003570433,CSF1/IL6/OCLN/TFF2/TFF3/TNFRSF11A/YAP1,7
GO:0001892,GO:0001892,embryonic placenta development,4/134,87/18800,0.0034787811538785,0.0271742011722321,0.0178823071982053,ADM/EGFR/KRT19/SPINT1,4
GO:0002709,GO:0002709,regulation of T cell mediated immunity,4/134,88/18800,0.0036246091581647,0.0281041123889226,0.0184942463657459,IL1R1/IL6/NECTIN2/TNFRSF1B,4
GO:0002831,GO:0002831,regulation of response to biotic stimulus,8/134,351/18800,0.0037078489463405,0.028135993220787,0.0185152259274089,CLEC6A/HAVCR2/IL15/LGALS9/MMP12/NECTIN2/TREM2/VSIG4,8
GO:0010713,GO:0010713,negative regulation of collagen metabolic process,2/134,13/18800,0.003735973686877,0.028135993220787,0.0185152259274089,CST3/IL6,2
GO:0036005,GO:0036005,response to macrophage colony-stimulating factor,2/134,13/18800,0.003735973686877,0.028135993220787,0.0185152259274089,CSF1/TREM2,2
GO:0045683,GO:0045683,negative regulation of epidermis development,2/134,13/18800,0.003735973686877,0.028135993220787,0.0185152259274089,DLL1/REG3A,2
GO:0001776,GO:0001776,leukocyte homeostasis,4/134,89/18800,0.0037745351483169,0.0283585600164718,0.0186616886619463,CD74/IL2RA/IL6/LGALS9,4
GO:0070997,GO:0070997,neuron death,8/134,353/18800,0.0038366212982216,0.0287563901114329,0.0189234855010031,C1QA/CHGA/CSF1/EPO/ITGAM/NEFL/TNFRSF1B/TREM2,8
GO:0070301,GO:0070301,cellular response to hydrogen peroxide,4/134,90/18800,0.0039286131246152,0.0293759480196887,0.0193311929722287,FABP1/HGF/IL18BP/IL6,4
GO:0070741,GO:0070741,response to interleukin-6,3/134,46/18800,0.0042971362705104,0.0317607974366108,0.0209005715760215,FGF23/IL6/YAP1,3
GO:0051960,GO:0051960,regulation of nervous system development,9/134,440/18800,0.0043185391678083,0.0317607974366108,0.0209005715760215,DLL1/HGF/IL6/NEFL/SPINT1/THBS2/TNFRSF1B/TREM2/YAP1,9
GO:0033033,GO:0033033,negative regulation of myeloid cell apoptotic process,2/134,14/18800,0.0043383554313032,0.0317607974366108,0.0209005715760215,CLEC5A/EPO,2
GO:0070278,GO:0070278,extracellular matrix constituent secretion,2/134,14/18800,0.0043383554313032,0.0317607974366108,0.0209005715760215,TNFRSF1A/TNFRSF1B,2
GO:1905208,GO:1905208,negative regulation of cardiocyte differentiation,2/134,14/18800,0.0043383554313032,0.0317607974366108,0.0209005715760215,DLL1/EGFR,2
GO:0032924,GO:0032924,activin receptor signaling pathway,3/134,47/18800,0.004566458703794,0.0331226082938795,0.0217967274534725,ACVRL1/FSTL3/TGFBR2,3
GO:0010862,GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation,3/134,49/18800,0.0051352218459835,0.0362459156303948,0.0238520570991162,ACVRL1/GDF15/TGFBR2,3
GO:0043300,GO:0043300,regulation of leukocyte degranulation,3/134,49/18800,0.0051352218459835,0.0362459156303948,0.0238520570991162,IL4R/ITGAM/LGALS9,3
GO:0006692,GO:0006692,prostanoid metabolic process,3/134,50/18800,0.0054348659376875,0.0378516769288503,0.0249087474740779,CD74/PTGDS/TNFRSF1A,3
GO:0006693,GO:0006693,prostaglandin metabolic process,3/134,50/18800,0.0054348659376875,0.0378516769288503,0.0249087474740779,CD74/PTGDS/TNFRSF1A,3
GO:0050764,GO:0050764,regulation of phagocytosis,4/134,99/18800,0.0055108457284023,0.0382961199845707,0.0252012185279326,IL15/ITGAV/SIRPB1/TREM2,4
GO:0030002,GO:0030002,cellular anion homeostasis,2/134,16/18800,0.0056678382887635,0.0389571068406719,0.0256361888124264,CKB/FGF23,2
GO:0034349,GO:0034349,glial cell apoptotic process,2/134,16/18800,0.0056678382887635,0.0389571068406719,0.0256361888124264,DLL1/TREM2,2
GO:0060046,GO:0060046,regulation of acrosome reaction,2/134,16/18800,0.0056678382887635,0.0389571068406719,0.0256361888124264,B4GALT1/SPINK1,2
GO:0014013,GO:0014013,regulation of gliogenesis,4/134,100/18800,0.005709315125101,0.039071573943083,0.0257115152544597,IL6/SPINT1/TNFRSF1B/TREM2,4
GO:0031341,GO:0031341,regulation of cell killing,4/134,100/18800,0.005709315125101,0.039071573943083,0.0257115152544597,HAVCR2/ITGAM/LGALS9/NECTIN2,4
GO:1905477,GO:1905477,positive regulation of protein localization to membrane,4/134,103/18800,0.0063332109150353,0.0427669972630974,0.0281433326468855,EGFR/EPHA2/ITGAM/TREM2,4
GO:0022600,GO:0022600,digestive system process,4/134,104/18800,0.0065508312770542,0.0427669972630974,0.0281433326468855,FABP1/SPINK1/TFF2/TFF3,4
GO:0006968,GO:0006968,cellular defense response,3/134,54/18800,0.006737393985515,0.0427669972630974,0.0281433326468855,CD300C/CLEC5A/CXCL9,3
GO:0010711,GO:0010711,negative regulation of collagen catabolic process,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,CST3,1
GO:0021688,GO:0021688,cerebellar molecular layer formation,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,DLL1,1
GO:0034151,GO:0034151,regulation of toll-like receptor 6 signaling pathway,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,TREM2,1
GO:0045960,GO:0045960,"positive regulation of complement activation, classical pathway",1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,TREM2,1
GO:0046814,GO:0046814,coreceptor-mediated virion attachment to host cell,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,NECTIN2,1
GO:0060311,GO:0060311,negative regulation of elastin catabolic process,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,CST3,1
GO:0060853,GO:0060853,Notch signaling pathway involved in arterial endothelial cell fate commitment,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,DLL1,1
GO:0070392,GO:0070392,detection of lipoteichoic acid,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,TREM2,1
GO:0075512,GO:0075512,clathrin-dependent endocytosis of virus by host cell,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,SIGLEC1,1
GO:0086030,GO:0086030,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,CHGA,1
GO:0090143,GO:0090143,nucleoid organization,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,CHCHD10,1
GO:0090144,GO:0090144,mitochondrial nucleoid organization,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,CHCHD10,1
GO:1903771,GO:1903771,positive regulation of beta-galactosidase activity,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,PSAP,1
GO:1905291,GO:1905291,positive regulation of CAMKK-AMPK signaling cascade,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,TREM2,1
GO:1905317,GO:1905317,inferior endocardial cushion morphogenesis,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,TGFBR2,1
GO:1905806,GO:1905806,regulation of synapse pruning,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,TREM2,1
GO:1905808,GO:1905808,positive regulation of synapse pruning,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,TREM2,1
GO:2000184,GO:2000184,positive regulation of progesterone biosynthetic process,1/134,1/18800,0.0071276595744684,0.0427669972630974,0.0281433326468855,ADM,1
GO:0001946,GO:0001946,lymphangiogenesis,2/134,18/18800,0.0071595322610077,0.0427669972630974,0.0281433326468855,ACVRL1/EPHA2,2
GO:0006957,GO:0006957,"complement activation, alternative pathway",2/134,18/18800,0.0071595322610077,0.0427669972630974,0.0281433326468855,C9/VSIG4,2
GO:0031643,GO:0031643,positive regulation of myelination,2/134,18/18800,0.0071595322610077,0.0427669972630974,0.0281433326468855,HGF/TNFRSF1B,2
GO:0034138,GO:0034138,toll-like receptor 3 signaling pathway,2/134,18/18800,0.0071595322610077,0.0427669972630974,0.0281433326468855,COLEC12/HAVCR2,2
GO:0048535,GO:0048535,lymph node development,2/134,18/18800,0.0071595322610077,0.0427669972630974,0.0281433326468855,IL15/TNFRSF11A,2
GO:0061298,GO:0061298,retina vasculature development in camera-type eye,2/134,19/18800,0.0079647022712953,0.0468698902390575,0.0308432903064486,ACVRL1/COL4A1,2
GO:0060249,GO:0060249,anatomical structure homeostasis,7/134,319/18800,0.0079654991352909,0.0468698902390575,0.0308432903064486,CSF1/IL6/OCLN/TFF2/TFF3/TNFRSF11A/YAP1,7
GO:0071772,GO:0071772,response to BMP,5/134,173/18800,0.0080171941781041,0.0469110172354493,0.0308703544169612,ACVRL1/FSTL3/GDF15/NBL1/SPINT1,5
GO:0071773,GO:0071773,cellular response to BMP stimulus,5/134,173/18800,0.0080171941781041,0.0469110172354493,0.0308703544169612,ACVRL1/FSTL3/GDF15/NBL1/SPINT1,5
GO:0071347,GO:0071347,cellular response to interleukin-1,4/134,111/18800,0.0082140831153951,0.0478850623097481,0.0315113363959019,CCL20/CCL7/IL1R1/IL6,4
GO:0031102,GO:0031102,neuron projection regeneration,3/134,59/18800,0.0086057297601745,0.0493457874044253,0.0324725839670665,ADM/HGF/NEFL,3
GO:0002837,GO:0002837,regulation of immune response to tumor cell,2/134,20/18800,0.0088086305170852,0.0496056688153565,0.0326436020292321,HAVCR2/NECTIN2,2
GO:0035313,GO:0035313,"wound healing, spreading of epidermal cells",2/134,20/18800,0.0088086305170852,0.0496056688153565,0.0326436020292321,ACVRL1/MMP12,2
GO:1902074,GO:1902074,response to salt,2/134,20/18800,0.0088086305170852,0.0496056688153565,0.0326436020292321,FGF23/NEFL,2
GO:1903978,GO:1903978,regulation of microglial cell activation,2/134,20/18800,0.0088086305170852,0.0496056688153565,0.0326436020292321,IL6/TREM2,2
